Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Clinical trial NCT01877694 · COMPLETED
Trial details
- NCT number
- NCT01877694
- Sponsor
- NovaBay Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2014-12-01
- Enrollment
- 217
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.